Effect of Ezetimibe on visceral fat suppression in patients with chronic liver disease and hyperlipidemia ; a randomized, double blind, placebo-controlled, clinical trial.
Phase of Trial: Phase II
Latest Information Update: 12 May 2012
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 12 May 2012 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 07 May 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 03 May 2011 New trial record